Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Af710 Compound
2. Af710b Compound
1. Af-710b
2. Anavex 3-71
3. Aae07z061b
4. 1235733-73-9
5. 1-propanone, 1-(2,8-dimethyl-1-thia-3,8-diazaspiro(4.5)dec-3-yl)-3-(1h-indol-3-yl)-
6. Unii-aae07z061b
7. Schembl1326705
8. Sb17189
9. 1-(2,8-dimethyl-1-thia-3,8-diazaspiro[4.5]dec-3-yl)-3-(1h-indol-3-yl) Propan-1-one
| Molecular Weight | 357.5 g/mol |
|---|---|
| Molecular Formula | C20H27N3OS |
| XLogP3 | 3.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 357.18748367 g/mol |
| Monoisotopic Mass | 357.18748367 g/mol |
| Topological Polar Surface Area | 64.6 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 491 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
81
PharmaCompass offers a list of AF710B API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right AF710B manufacturer or AF710B supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred AF710B manufacturer or AF710B supplier.
PharmaCompass also assists you with knowing the AF710B API Price utilized in the formulation of products. AF710B API Price is not always fixed or binding as the AF710B Price is obtained through a variety of data sources. The AF710B Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A AF710B manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AF710B, including repackagers and relabelers. The FDA regulates AF710B manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AF710B API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A AF710B supplier is an individual or a company that provides AF710B active pharmaceutical ingredient (API) or AF710B finished formulations upon request. The AF710B suppliers may include AF710B API manufacturers, exporters, distributors and traders.
AF710B Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of AF710B GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right AF710B GMP manufacturer or AF710B GMP API supplier for your needs.
A AF710B CoA (Certificate of Analysis) is a formal document that attests to AF710B's compliance with AF710B specifications and serves as a tool for batch-level quality control.
AF710B CoA mostly includes findings from lab analyses of a specific batch. For each AF710B CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
AF710B may be tested according to a variety of international standards, such as European Pharmacopoeia (AF710B EP), AF710B JP (Japanese Pharmacopeia) and the US Pharmacopoeia (AF710B USP).
